Cargando…

68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology

ABSTRACT IMPACT: The proposed study has the potential to inform new paradigms of type 1 diabetes prevention and therapy with the overall goal of improving β cell health during autoimmunity. OBJECTIVES/GOALS: Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic βcells. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Weaver, Staci A., Kono, Tatsuyoshi, Syed, Farooq, Bone, Robert, Evans-Molina, Carmella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827744/
http://dx.doi.org/10.1017/cts.2021.446
_version_ 1784647701379416064
author Weaver, Staci A.
Kono, Tatsuyoshi
Syed, Farooq
Bone, Robert
Evans-Molina, Carmella
author_facet Weaver, Staci A.
Kono, Tatsuyoshi
Syed, Farooq
Bone, Robert
Evans-Molina, Carmella
author_sort Weaver, Staci A.
collection PubMed
description ABSTRACT IMPACT: The proposed study has the potential to inform new paradigms of type 1 diabetes prevention and therapy with the overall goal of improving β cell health during autoimmunity. OBJECTIVES/GOALS: Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic βcells. Recent data suggest that activation of senescence and acquisition of a senescence associated secretory phenotype (SASP) by βcells may contribute to T1D pathogenesis. However, the molecular mechanisms responsible for this phenotype are not well understood. METHODS/STUDY POPULATION: We hypothesize that loss of endoplasmic reticulum (ER) Ca2+ induces βcell senescence, SASP as well as mitochondrial dysfunction which drive T1D development. The current study utilizes SERCA2 KO INS-1 βcells (S2KO) exhibiting loss of ER Ca2+ and a SERCA2 haploinsufficient mice on a non-obese diabetic background (NOD-S2+/-) to test the role of ER Ca2+ loss during T1D development. Senescence associated βgalactosidase staining (SA-βgal), expression of senescence markers (RT-qPCR), mitochondrial function (Seahorse, TMRM) and mitochondrial copy number (qPCR) were all measured in S2KO versus WT βcells and are currently being measured in the NOD-S2+/- mouse model at 6, 8, 12, 14, and 16wks of age. RESULTS/ANTICIPATED RESULTS: RT-qPCR assays detecting senescence markers cdkn1a and cdkn2a and mitochondrial specific genes cox1 and nd1 were developed and validated in both INS-1 βcells and mouse islets. Mitochondrial function assay (Seahorse) was optimized for use in INS-1 βcells and is currently under development for use in intact mouse islets. S2KO βcells displayed increased SA- βgal staining as well as increased mitochondrial coupling efficiency (p=0.0146) and baseline mitochondrial copy number (p=0.0053) compared to WT βcells, suggesting a senescence phenotype and altered mitochondrial function. NOD-S2+/- mice exhibited increased expression of the senescence marker cdkn2a in the islet at 12wks (p=0.0117) compared to control mice, whereas cdkn1a remained unchanged across all timepoints tested. DISCUSSION/SIGNIFICANCE OF FINDINGS: Our results suggest that loss of SERCA2 and reduced ER Ca2+ alter βcell mitochondrial function and are associated with features of senescence. Future studies will test whether SERCA2 activation and/or senolytic/senomorphic drugs are able to prevent or delay diabetes onset in NOD-S2+/- mice.
format Online
Article
Text
id pubmed-8827744
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88277442022-02-28 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology Weaver, Staci A. Kono, Tatsuyoshi Syed, Farooq Bone, Robert Evans-Molina, Carmella J Clin Transl Sci Basic Science ABSTRACT IMPACT: The proposed study has the potential to inform new paradigms of type 1 diabetes prevention and therapy with the overall goal of improving β cell health during autoimmunity. OBJECTIVES/GOALS: Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic βcells. Recent data suggest that activation of senescence and acquisition of a senescence associated secretory phenotype (SASP) by βcells may contribute to T1D pathogenesis. However, the molecular mechanisms responsible for this phenotype are not well understood. METHODS/STUDY POPULATION: We hypothesize that loss of endoplasmic reticulum (ER) Ca2+ induces βcell senescence, SASP as well as mitochondrial dysfunction which drive T1D development. The current study utilizes SERCA2 KO INS-1 βcells (S2KO) exhibiting loss of ER Ca2+ and a SERCA2 haploinsufficient mice on a non-obese diabetic background (NOD-S2+/-) to test the role of ER Ca2+ loss during T1D development. Senescence associated βgalactosidase staining (SA-βgal), expression of senescence markers (RT-qPCR), mitochondrial function (Seahorse, TMRM) and mitochondrial copy number (qPCR) were all measured in S2KO versus WT βcells and are currently being measured in the NOD-S2+/- mouse model at 6, 8, 12, 14, and 16wks of age. RESULTS/ANTICIPATED RESULTS: RT-qPCR assays detecting senescence markers cdkn1a and cdkn2a and mitochondrial specific genes cox1 and nd1 were developed and validated in both INS-1 βcells and mouse islets. Mitochondrial function assay (Seahorse) was optimized for use in INS-1 βcells and is currently under development for use in intact mouse islets. S2KO βcells displayed increased SA- βgal staining as well as increased mitochondrial coupling efficiency (p=0.0146) and baseline mitochondrial copy number (p=0.0053) compared to WT βcells, suggesting a senescence phenotype and altered mitochondrial function. NOD-S2+/- mice exhibited increased expression of the senescence marker cdkn2a in the islet at 12wks (p=0.0117) compared to control mice, whereas cdkn1a remained unchanged across all timepoints tested. DISCUSSION/SIGNIFICANCE OF FINDINGS: Our results suggest that loss of SERCA2 and reduced ER Ca2+ alter βcell mitochondrial function and are associated with features of senescence. Future studies will test whether SERCA2 activation and/or senolytic/senomorphic drugs are able to prevent or delay diabetes onset in NOD-S2+/- mice. Cambridge University Press 2021-03-30 /pmc/articles/PMC8827744/ http://dx.doi.org/10.1017/cts.2021.446 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Basic Science
Weaver, Staci A.
Kono, Tatsuyoshi
Syed, Farooq
Bone, Robert
Evans-Molina, Carmella
68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_full 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_fullStr 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_full_unstemmed 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_short 68722 Role of ER calcium in beta cell senescence and diabetes pathophysiology
title_sort 68722 role of er calcium in beta cell senescence and diabetes pathophysiology
topic Basic Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827744/
http://dx.doi.org/10.1017/cts.2021.446
work_keys_str_mv AT weaverstacia 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT konotatsuyoshi 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT syedfarooq 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT bonerobert 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology
AT evansmolinacarmella 68722roleofercalciuminbetacellsenescenceanddiabetespathophysiology